Medical liability insurance as a barrier to the provision of abortion services in family medicine

American Journal of Public Health

Volumn 98, Issue 10, 2008, Pages 1770-1774

  Dehlendorf, Christine E ^a,b,c   Grumbach, Kevin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; FAMILY MEDICINE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; MEDICAL DECISION MAKING; MEDICAL PROFESSION; PRIMARY HEALTH CARE; REVIEW; ECONOMICS; FEMALE; GENERAL PRACTICE; HEALTH CARE DELIVERY; INSURANCE; LEGAL ABORTION; LEGAL LIABILITY; MALPRACTICE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT ADVOCACY; PHYSICIAN ATTITUDE; PREGNANCY; PROFESSIONAL PRACTICE; STATISTICAL ANALYSIS; STATISTICS; UNITED STATES;

ABORTIVE AGENT; MIFEPRISTONE;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, LEGAL; ACTUARIAL ANALYSIS; FAMILY PRACTICE; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE COVERAGE; INSURANCE, LIABILITY; LIABILITY, LEGAL; MALPRACTICE; MIFEPRISTONE; PATIENT ADVOCACY; PHYSICIAN'S ROLE; PREGNANCY; PRIMARY HEALTH CARE; PROFESSIONAL AUTONOMY; UNITED STATES;

EID: 52449097260     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.136325     Document Type: Review

References (33)

1. Jones RK, Zolna MR, Henshaw SK, Finer LB. Abortion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health. 2008;40:6-16.
2. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30:24-29,46.
3. Finer LB, Henshaw SK. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health. 2003;35(1):6-15.
4. Dehlendorf C, Brahmi D, Engel D, Grumbach K, Joffe C, Gold M. Integrating abortion training into family medicine residency programs. Fam Med. 2007;39:337-342.
5. Lesnewski R, Prine L, Gold M. New research abortion training as an integral part of residency training [letter]. Fam Med. 2003;35:386-387.
6. Hakim-Elahi E, Tovell HMM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76:129-135.
7. Henderson JT, Hwang AC, Harper CC, Stewart FH. Safety of mifepristone abortions in clinical use. Contraception. 2005;72:175-178.
8. Fryer GE, Green LA, Dovey SM, Philips RI Jr. The United States relies on family physicians unlike any other specialty. Am Fam Physician. 2001;63:1669.
9. Joffe C. Medical abortion in social context. Am J Obstet Gynecol. 2000;183(2 suppl):S10-S15.
10. Bridging the gap between abortion training and provision. Recommendations from a national symposium, October 23, 2000. Available at: http://www. prochoice.org/pubs_research/publications/downloads/professional_education/ Bridging_the_Gap_Training_Symp.pdf. Accessed February 12, 2007.
11. American Academy of Family Physicians practice profile survey I, 2003. Available at: http://www.aafp.org/fpm/20030900/monitor.html. Accessed February 10, 2007.
12. Schwarz EB, Luetkemeyer A, Foster DG, Weitz TA, Lindes D, Stewart FH Willing and able? Provision of medication for abortion by future internists. Womens Health Issues. 2005;15:39-44.
13. Samora JB, Leslie N. The role of advanced practice clinicians in the availability of abortion services in the United States. J Obstet Gynecol Neonatal Nurs. 2007;36:471-476.
14. American Academy of Family Physicians. Core curriculum guidelines: maternity and gynecologic care. Available at: http://www.aafp.org/afp/980700ap/ corematr.html. Accessed July 5, 2008.
15. Lichtenberg ES, Paul M, Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2001;64:345-352.
16. Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA. 2000;284:1948-1953.
17. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 1999;59:1-6.
18. Prine LW, Lesnewski R. Medication abortion and family physicians' scope of practice. J Am Board Fam Pract. 2005;18:304-306.
19. Prine L, Lesnewski R, Berley N, Gold M. Medical abortion in family practice: a case series. J Am Board Fam Pract. 2003;16:290-295.
20. Westfall JM, Sophocles A, Burggraf H, Ellis S. Manual vacuum aspiration for first-trimester abortion. Arch Fam Med. 1998;7:559-562.
21. Paul M, Nobel K, Goodman S, Lossy P, Moschella JE, Hammer H. Abortion training in three family medicine programs: resident and patient outcomes. Fam Med. 2007;39:184-189.
22. American Academy of Family Physicians. Colonoscopy (position paper). Available at: http://www.aafp.org/online/en/home/policy/policies/c/ colonoscopypositionpaper.html. Accessed July 9, 2008.
23. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol. 2004;103:729-737.
24. Vats V, Nutescu E, Blackburn JC, et al. Efficacy and safety of warfarin management in US anticoagulation clinic. J Thromb Thrombolysis. 2008 Feb;25:131.
25. Mehlhorn AJ. Safety concerns with fluoroquinolones. Ann Pharmacother. 2007;41:1859-1866.
26. Food and Drug Administration. Product labeling for Lotensin. Available at: http://www.fda.gov/cder/foi/label/2004/019851s028lbl.pdf. Accessed January 24, 2008.
27. Keeton RE, Widiss AI. Insurance Law: A Guide to Fundamental Principles, Legal Doctrines, and Commercial Practice. St Paul, MN: West Publishing; 1988:§4.8(b) at 965.
28. Medical Malpractice Insurance: Multiple Factors Have Contributed to Increased Premium Rates. Washington, DC: Government Accountability Office; June 27, 2003. GAO-03-702.
29. Dailard C. Contraceptive Coverage: a 10-year retrospective. Guttmacher Rep Public Policy. 2004;7(2):6-9.
30. Wynn LL, Trussell J. Images of American sexuality in debates over non-prescription access to emergency contraceptive pills. Obstet Gynecol. 2006;108(5):1272-1276.
31. Segal SJ. Liability concerns in contraceptive research and development. Int J Gynaecol Obstet. 1999;67:S141-S151.
32. American Academy of Family Physicians. Professional medical liability. Available at: http://www.aafp.org/online/en/home/policy/policies/p/ professionalmedicaliability.html. Accessed January 23, 2008.
33. Keeton RE, Widiss AI. Insurance Law: A Guide to Fundamental Principles, Legal Doctrines, and Commercial Practice. St Paul, MN:West Publishing; 1988:§4.8(b) at 963-967.